Myasthenia gravis

Anthony Kincaid

doi:10.1016/B978-008055232-3.60686-5

Myasthenia gravis

Anthony Kincaid

Department of Pharmacy Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

Original language	English (US)
Title of host publication	xPharm
Subtitle of host publication	The Comprehensive Pharmacology Reference
Publisher	Elsevier Inc.
Pages	1-5
Number of pages	5
ISBN (Print)	9780080552323
DOIs	https://doi.org/10.1016/B978-008055232-3.60686-5
State	Published - Jan 1 2007

All Science Journal Classification (ASJC) codes

Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1016/B978-008055232-3.60686-5

Fingerprint Dive into the research topics of 'Myasthenia gravis'. Together they form a unique fingerprint.

Cite this

@inbook{7bb1a71978474f11b388b71994fb87f6,

title = "Myasthenia gravis",

abstract = "Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....",

author = "Anthony Kincaid",

year = "2007",

month = jan,

day = "1",

doi = "10.1016/B978-008055232-3.60686-5",

language = "English (US)",

isbn = "9780080552323",

pages = "1--5",

booktitle = "xPharm",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Myasthenia gravis

AU - Kincaid, Anthony

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

AB - Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

UR - http://www.scopus.com/inward/record.url?scp=84884059540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884059540&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.60686-5

DO - 10.1016/B978-008055232-3.60686-5

M3 - Chapter

SN - 9780080552323

SP - 1

EP - 5

BT - xPharm

PB - Elsevier Inc.

ER -

Myasthenia gravis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this